Molecular genetics of hemophilia A: Clinical perspectives

Tantawy, Azza A. G.
November 2010
Egyptian Journal of Medical Human Genetics;2010, Vol. 11 Issue 2, p105
Academic Journal
Since the publication of the sequence of the factor VIII (F8) gene in 1984, a large number of mutations that cause hemophilia A have been identified and a significant progress has been made in translating this knowledge for clinical diagnostic and therapeutic purposes. Molecular genetic testing is used to determine the carrier status, for prenatal diagnosis, for prediction of the likelihood of inhibitor development, and even can be possibly used to predict responsiveness to immune tolerance induction. Phenotypic heterogeneity of hemophilia is multifactorial, mainly related to F8 mutation but other factors contribute especially to coinheritance of prothrombotic genes. Inhibitor development is mainly related to F8 null mutations, but other genetic and non genetic factors could contribute. This review will focus on the genetic aspects of hemophilia A and their application in the clinical setting and the care of patients and their families.


Related Articles

  • Importance of immune response genes in hemophilia A. de Alencar, Josiane Bazzo; Macedo, Luciana Conci; de Barros, Morgana Ferreira; Rodrigues, Camila; Cadide, Renata Campos; Sell, Ana Maria; Visentainer, Jeane Eliete Laguila // Revista Brasileira de Hematologia e Hemoterapia;2013, Vol. 35 Issue 4, p280 

    Hemophilia A is a disease caused by a deficiency of coagulation factor VIII resulting from genetic inheritance linked to chromosome X. One treatment option is the administration of plasma or recombinant FVIII. However, some patients develop inhibitors or antibodies against this factor....

  • A case series of acquired haemophilia in a Malaysian hospital: unpredictably rare medical emergency. Chiou Perng Lee; Bt Khalid, Bahariah // Oxford Medical Case Reports;Oct2015, Vol. 2015 Issue 10, p330 

    Acquired haemophilia (AH) is a rare bleeding disorder characterized by the presence of acquired inhibitors against Factor VIII causing disruption of coagulation cascade. It has no known genetic inheritance, and diagnosis remains a challenge. The peculiar presentations are later age of onset as...

  • The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance. Sayınalp, N.; Haznedaroǧlu, I. C.; Aksu, S.; Büyükaşık, Y.; Göker, H.; Parlak, H.; Özcebe, O. I.; Kirazlı, Ş; Dündar, S. V.; Gürgey, A. // Clinical & Applied Thrombosis/Hemostasis;Jul2004, Vol. 10 Issue 3, p265 

    After the discovery of activated protein C resistance (APCR) due to factor V Leiden mutation and the causal relationship of the phenomenon with clinical thromboembolism, a wide variety of functional clotting-based assays were developed for testing of APCR in relation to the specific DNA-based...

  • Gene therapy: Genie in a vector. Gould, Julie // Nature;11/27/2014 Supplement, Vol. 515 Issue s7528, pS160 

    The article discusses challenges faced by researchers trying to repair faulty genes causing haemophilia especially in children. Treatments include the infusion of a functional factor IX gene along with DNA to control clotting factor, and a form of gene therapy called genome editing. Research by...

  • Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy. Burlet, Philippe; Gigarel, Nadine; Magen, Maryse; Drunat, Séverine; Benachi, Alexandra; Hesters, Laetitia; Munnich, Arnold; Bonnefont, Jean-Paul; Steffann, Julie // European Journal of Human Genetics;Apr2010, Vol. 18 Issue 4, p505 

    With the detection of a homozygous deletion of the survival motor neuron 1 gene (SMN1), prenatal and preimplantation genetic diagnosis (PGD) for spinal muscular atrophy has become feasible and widely applied. The finding of a de novo rearrangement, resulting in the loss of the SMN1 gene, reduces...

  • Randomization techniques for assessing the significance of gene periodicity results.  // BMC Bioinformatics;2011 Supplement 6, Vol. 12 Issue Suppl 6, p330 

    The article offers information on the study conducted by the authors related to randomization techniques for assessing the significance of gene periodicity results. It states that by reanalyzing gene cycle data from various sources, we show how previous estimates on the number of gene cycle...

  • Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy. Sack, Brandon K.; Merchant, Sherin; Markusic, David M.; Nathwani, Amit C.; Davidoff, Andrew M.; Byrne, Barry J.; Herzog, Roland W. // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    The major complication in the treatment of hemophilia A is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). The current method for eradicating inhibitors, termed immune tolerance induction (ITI), is costly and protracted. Clinical protocols that prevent rather...

  • Genetics: uphold the rights of all clients to informed decision-making and voluntary action. Haydon, Jo // Nursing Standard;9/28/2005, Vol. 20 Issue 3, p48 

    This article discusses the rights of patients in relation to types of genetic tests and the broader implications for families. Use and misuse of genetic information is considered, including scenarios and points to consider. The use of a non-directive approach in genetic counselling is emphasised...

  • DIAGNÓSTICO GENÉTICO PRÉ-IMPLANTAÇÃO. TELES, Natália OLIVA // Acta Medica Portuguesa;2011, Vol. 24 Issue 6, p987 

    Following the advances in the techniques of medically assisted reproduction (ART), 1990 has seen the first born child after the development of pre-implantation genetic diagnosis. In this analysis embryos are tested for the presence of genetic anomalies at three to five days after fertilization...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics